Ondansetron HCL 4 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FSDYL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,439
Award facts
- Contract value 100% obligated
- $23,438.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ondansetron HCl 4 mg tablets in quantities of 30, with a ceiling value of $23,438.54. This is a firm fixed price delivery order with no set-aside designation, completed through open competition. The order is scheduled for ultimate completion by September 2, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor headquartered in Pennsylvania that supplies an extensive portfolio of medications and medical supplies to military and veteran healthcare systems. The company's federal contract performance demonstrates consistent capability in fulfilling diverse pharmaceutical procurement requirements through the DLA Medical Supply Chain, serving customers including the Defense Health Agency and U.S. Coast Guard. Ondansetron, an antiemetic medication commonly used in medical settings, represents a typical pharmaceutical product within AmerisourceBergen's federal supply portfolio, which encompasses everything from specialty medications to vaccines and medical devices across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FSDYL?
SPE2DB25FSDYL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FSDYL worth?
The government has obligated $23,439 on SPE2DB25FSDYL.
Is contract SPE2DB25FSDYL an order under another contract?
Yes. SPE2DB25FSDYL is a delivery order under SPE2DB22D2211, an indefinite delivery contract.
Was contract SPE2DB25FSDYL competed?
The extent of competition for SPE2DB25FSDYL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award